We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Full Spectrum Laboratories Secures U.S. Cannabinoid Biosynthesis Patent

News   Jan 09, 2017 | Original Story From Teewinot Life Sciences Corporation

 
Full Spectrum Laboratories Secures U.S. Cannabinoid Biosynthesis Patent
 
 
Advertisement
 

RELATED ARTICLES

X-Ray Method Tracks How Proteins Fold

News

KAIST researchers have used an X-ray method to track how proteins fold, which could improve computer simulations of this process, with implications for understanding diseases and improving drug discovery.

READ MORE

Drug for Inherited ALS Shows Promise in Early-stage Trial

News

A trial of an experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in an early-stage trial.

READ MORE

Gene Program Initiates Brain Changes in Response to Cocaine

News

A research team has used single-nucleus RNA sequencing approaches to compare transcriptional responses to acute cocaine in 16 unique cell populations from a portion of the brain called the nucleus accumbens, or NAc.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE